Analysis of Coronavirus-Host Cell Interactions

冠状病毒-宿主细胞相互作用分析

基本信息

  • 批准号:
    8442842
  • 负责人:
  • 金额:
    $ 35.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-15 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The translation of the viral genome begins immediately after coronavirus (CoV) infection to produce two large polyproteins that are processed into 15 or 16 mature, nonstructural proteins. Most of these proteins are involved in viral RNA synthesis, and some have other biological functions. The nsp1 protein of betaCoVs, which includes SARS-CoV (SCoV), bat CoVs, and mouse hepatitis virus (MHV), and of alphaCoVs, which includes transmissible gastroenteritis virus (TGEV) and human CoV 229E, inhibits host gene expression. As past studies have shown that viral proteins that inhibit host gene expression are major virulence factors, nsp1 proteins of CoVs most probably play a critical role in CoV pathogenesis. Consistent with this notion, MHV nsp1 is a major virulence factor, and SCoV nsp1 inhibits the production of type I interferon and interferon-stimulated genes in infected cells. Nsp1 proteins of different CoVs share a common biological function to inhibit host gene expression but use different strategies to exert this function. SCoV nsp1 uses a novel, two-pronged strategy to inhibit host protein synthesis/gene expression. SCoV nsp1 binds to the 40S ribosomal subunit to inhibit mRNA translation and also induces a template-dependent endonucleolytic mRNA cleavage. In contrast to SCoV nsp1, TGEV nsp1 employs a different strategy to inhibit mRNA translation, as it is unable to bind the 40S ribosomal subunit or promote host mRNA degradation. This application aims to delineate the novel mechanisms of CoV nsp1-induced inhibition of gene expression by using SCoV and TGEV nsp1 proteins as model systems. We will uncover the mechanism of SCoV nsp1-induced template-dependent mRNA cleavage. We will also clarify the different mechanisms of SCoV and TGEV nsp1-induced translation inhibition and reveal the strategy that allows robust viral gene expression in SCoV-infected cells under conditions of nsp1-induced translation inhibition. The proposed studies will provide a foundation for understanding the modulation of host gene expression by CoV, expand our knowledge of CoV pathogenicity at the molecular level, and potentially identify a novel mechanism for the regulation of eukaryotic gene expression.
描述(由申请人提供):病毒基因组的翻译在冠状病毒(CoV)感染后立即开始,产生两个大的多聚蛋白,加工成15或16个成熟的非结构蛋白。这些蛋白质中的大多数参与病毒RNA的合成,有些还具有其他生物学功能。包括SARS-CoV(SCoV)、蝙蝠CoV和小鼠肝炎病毒(MHV)在内的betaCoV和包括传染性胃肠炎病毒(TGEV)和人CoV 229 E在内的alphaCoV的nsp 1蛋白抑制宿主基因表达。过去的研究表明,抑制宿主基因表达的病毒蛋白是主要的毒力因子,CoV的nsp 1蛋白很可能在CoV的致病中起关键作用。与这一观点一致,MHV nsp 1是一个主要的毒力因子,而SCoV nsp 1抑制感染细胞中I型干扰素和干扰素刺激基因的产生。不同冠状病毒的Nsp 1蛋白具有共同的生物学功能,抑制宿主基因表达,但使用不同的策略来发挥这一功能。SCoV nsp 1使用一种新的双管齐下的策略来抑制宿主蛋白质合成/基因表达。SCoV nsp 1与40 S核糖体亚基结合以抑制mRNA翻译,并且还诱导模板依赖性核酸内切mRNA切割。与SCoV nsp 1相反,TGEV nsp 1采用不同的策略来抑制mRNA翻译,因为它不能结合40 S核糖体亚基或促进宿主mRNA降解。本申请旨在通过使用SCoV和TGEV nsp 1蛋白作为模型系统来描绘CoV nsp 1诱导的基因表达抑制的新机制。我们将揭示SCoV nsp 1诱导的模板依赖性mRNA切割的机制。我们还将阐明SCoV和TGEV nsp 1诱导的翻译抑制的不同机制,并揭示在nsp 1诱导的翻译抑制条件下,允许在SCoV感染的细胞中稳健的病毒基因表达的策略。这些研究将为理解CoV对宿主基因表达的调控奠定基础,在分子水平上扩展我们对CoV致病性的认识,并可能确定真核基因表达调控的新机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shinji Makino其他文献

Shinji Makino的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shinji Makino', 18)}}的其他基金

Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
  • 批准号:
    10057583
  • 财政年份:
    2020
  • 资助金额:
    $ 35.96万
  • 项目类别:
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
  • 批准号:
    10188412
  • 财政年份:
    2020
  • 资助金额:
    $ 35.96万
  • 项目类别:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用
  • 批准号:
    10358595
  • 财政年份:
    2020
  • 资助金额:
    $ 35.96万
  • 项目类别:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用
  • 批准号:
    10614383
  • 财政年份:
    2020
  • 资助金额:
    $ 35.96万
  • 项目类别:
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine
新型裂谷热病毒减毒疫苗的合理研制
  • 批准号:
    9386475
  • 财政年份:
    2017
  • 资助金额:
    $ 35.96万
  • 项目类别:
Development of Safer,Live Attenuated Rift Valley Fever Vaccines
开发更安全的裂谷热减毒活疫苗
  • 批准号:
    9091408
  • 财政年份:
    2015
  • 资助金额:
    $ 35.96万
  • 项目类别:
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1
MERS 冠状病毒 nsp1 宿主和病毒基因调控的新范式
  • 批准号:
    9189963
  • 财政年份:
    2015
  • 资助金额:
    $ 35.96万
  • 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
  • 批准号:
    8604678
  • 财政年份:
    2013
  • 资助金额:
    $ 35.96万
  • 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
  • 批准号:
    8509347
  • 财政年份:
    2013
  • 资助金额:
    $ 35.96万
  • 项目类别:
Analysis of Coronavirus-Host Cell Interactions
冠状病毒-宿主细胞相互作用分析
  • 批准号:
    8888201
  • 财政年份:
    2012
  • 资助金额:
    $ 35.96万
  • 项目类别:

相似海外基金

Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
  • 批准号:
    573541-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.96万
  • 项目类别:
    University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
  • 批准号:
    2744317
  • 财政年份:
    2022
  • 资助金额:
    $ 35.96万
  • 项目类别:
    Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
  • 批准号:
    MR/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 35.96万
  • 项目类别:
    Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10019570
  • 财政年份:
    2019
  • 资助金额:
    $ 35.96万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10223370
  • 财政年份:
    2019
  • 资助金额:
    $ 35.96万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10455108
  • 财政年份:
    2019
  • 资助金额:
    $ 35.96万
  • 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
  • 批准号:
    255762
  • 财政年份:
    2012
  • 资助金额:
    $ 35.96万
  • 项目类别:
    Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
  • 批准号:
    20790351
  • 财政年份:
    2008
  • 资助金额:
    $ 35.96万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
  • 批准号:
    19370021
  • 财政年份:
    2007
  • 资助金额:
    $ 35.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
  • 批准号:
    7131841
  • 财政年份:
    2006
  • 资助金额:
    $ 35.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了